Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 February, 2018 15:50 IST
Indoco Remedies gets 8 USFDA observations for its Goa unit
Source: IRIS | 14 Feb, 2018, 10.09AM
Comments  |  Post Comment

Indoco Remedies has informed that USFDA inspected its solid dosage plant in Goa (Unit I). At the end of the inspection, the plant has received 8 observations (483s). The filling indicates that all the observations are correctable and the company is in the process of preparing its response for the same.

Exports from Goa solid dosage plant constitute less than 10% of the Indoco’s total exports and less than 4% of the total sales.

Shares of the company declined Rs 6.45, or 2.33%, to trade at Rs 269.90. The total volume of shares traded was 7,323 at the BSE (9.59 a.m., Wednesday).





Indoco Remedies Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Glenmark Pharma presents findings from Phase 2a study of GBR 830 - 19-Feb-2018 10:10
L&T Construction secures order worth Rs 16.80 bn - 19-Feb-2018 09:52
BHEL commissions 18 MW hydro-electric project in Punjab - 16-Feb-2018 13:33
Reliance Communication update on asset monetization - 16-Feb-2018 12:06
8K Miles Software launches blockchain platform 8K Health Edge - 16-Feb-2018 10:16
Mahindra Group to invest Rs 1.76 bn in Zoomcar - 16-Feb-2018 10:06
Larsen & Toubro bags orders worth Rs 15.85 bn - 15-Feb-2018 13:11
Rajesh Exports wins export order worth Rs 8.73 bn - 15-Feb-2018 12:36
Torrent Power secures wind power projects worth 499.8 MW - 15-Feb-2018 10:09
Torrent Power signs agreement with Siemens Gamesa Renewable Power - 15-Feb-2018 10:08
Zee Learn inks pact to invest Rs 2 bn in MT Educare - 15-Feb-2018 10:01
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer